Impact of malaria rapid diagnostic tests on prescription patterns of artemisinin-based combination therapy in Oyo State, Nigeria.

Autor:	Ige OK; Malaria Action Program for States, Oyo Office, Ibadan, Nigeria., Ayandipo EO; Malaria Action Program for States, Oyo Office, Ibadan, Nigeria.
Jazyk:	angličtina
Zdroj:	MalariaWorld journal [Malariaworld J] 2014 Feb 04; Vol. 5, pp. 2. Date of Electronic Publication: 2014 Feb 04 (Print Publication: 2014).
DOI:	10.5281/zenodo.10878438
Abstrakt:	Background: In the era of valuable and costly artemisinin-based combination therapy (ACT) for malaria it has been recommended that the use of ACTs is restricted to only those with confirmed positive malaria diagnosis. The potential benefits of rapid diagnostic tests (RDTs) on anti-malarial drug consumption have been demonstrated in a number of clinical trials. It is unknown if the introduction of RDTs in Nigeria has achieved the desired goal of reducing ACT consumption. This article assesses the impact of a state-wide roll-out of RDTs on ACT prescription in Oyo State, Nigeria. Materials and Methods: ACT prescribing patterns for febrile patients were compared pre- and post-RDT introduction in 106 primary health care facilities. Routine data from the national malaria control programme monthly facility summary forms were extracted for three months before and after the RDT intervention and compared using a 'before and after' design. Results: RDT testing rates for patients with fever revealed no trend; mean testing rate in the post RDT period was 64.5%. The mean malaria positivity rate was 71.3%, which equalled a proportional morbidity rate of 45.9% of all fever cases. ACT treatment to confirmed case ratio was consistently above the expected value of one and the ratio of treatment to tested patient exceeded one (mean ratio of 1.1) for the three months post RDT. The absolute number of ACT doses prescribed increased remarkably after the introduction of RDTs and ACTs revealing an extra utilisation of 14,199 doses, 5,534 (±517) versus 10,267 (±2,452), p<0.001. Relative Risk of ACT prescription in the post RDT period was 1.71 (1.33-2.25). Conclusion: There is notable non-adherence to RDT results, with an increase in ACT prescriptions after the initial introductory period for RDTs. This over reliance on ACTs for the management of non-malaria illness could compromise gains from reducing malaria morbidity and mortality and needs to be addressed urgently. Competing Interests: Competing Interests: No competing interests declared. (Copyright © 2014: O.K. Ige and E.O. Ayandipo.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu